Background and objectives: Lupus nephritis is one of the most common complications of Systemic Lupus Erythematosus, due to the accumulation of immunocomplexes of antigens and antibodies at the renal level. In the laboratory, serum anti-C1q antibody levels have become an important tool for monitoring and management of this disease. This study evidences the levels of anti-C1q as a marker of renal involvement in patients with SLE. Patients and methods: The study was descriptive and cross-sectional. The sample consisted of 44 patients who met the proposed inclusion criteria. Results: 90.91% of the patients were female and the remaining 9.09% were male. Regarding age, the predominant age group was 38 - 54 years 52.27%. 100% of the participants reported being Hispanic. The frequency of anti-C1q was 38.63%. The levels of anti-C1q antibodies were related to the results of C3, C4, anti-DNAs and urinary sediment which were statistically significant (p < 0.05) according to fisher’s exact test. Conclusions: Anti-C1q antibodies are significant as markers of renal involvement in lupus patients, when performed in conjunction with complement fractions c3 and c4, anti-DNAs antibodies.
Cite this paper
Gó, A. E. , mez-Sifontes, Diaz-Tablero, J. A. and Rodriguez, Y. J. G. G. (2025). Anti-C1q Antibodies as Markers of Renal Involvement in Patients with Systemic Lupus Erythematosus, Bolivar City, Venezuela. Open Access Library Journal, 12, e2987. doi: http://dx.doi.org/10.4236/oalib.1112987.
Anders, H., Saxena, R., Zhao, M., Parodis, I., Salmon, J.E. and Mohan, C. (2020) Lupus Nephritis. Nature Reviews Disease Primers, 6, Article No. 7. https://doi.org/10.1038/s41572-019-0141-9
Morales, E. and Gutierrez, E. (2021) Glomerulonephri-tis Associated with Complement Alterations. Nefrología al día, 12, 2659-2606.
https://www.nefrologiaaldia.org/es-articulo-glomerulonefr
itis-asociadas-a-alteraciones-del-complemento-619
Potlukova, E. and Kralikova, P. (2008) Complement Component C1q and Anti-C1q Antibodies in Theory and in Clinical Practice. Scandinavian Journal of Immunology, 67, 423-430. https://doi.org/10.1111/j.1365-3083.2008.02089.x
de Liso, F., Matinato, C., Novembrino, C., Radice, A., Raffiotta, F., Ronchi, M., et al. (2015) Value of a Commercial Kit for Detecting An-ti-C1q Autoantibodies and Correlation with Immunological and Clinical Activity of Lupus Nephritis. Clinical Chemistry and Laboratory Medicine (CCLM), 53, 1771-1777. https://doi.org/10.1515/cclm-2015-0072
Almaani, S., Meara, A. and Rovin, B.H. (2016) Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology, 12, 825-835. https://doi.org/10.2215/cjn.05780616
The World Medical Association (2013) Declaration of Helsinki—Ethical Prin-ciples for Medical Research Involving Medical Research Involving Human Subjects (64th General Assembly, Fortaleza, Brazil, 2013). https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
López, Y.P., González, L.A., Restrepo, M., Rodríguez, L.M., León, A.L., Severiche, D., et al. (2013) Anticuerpos Anti-C1q como marcadores de compromiso renal en pacientes con lupus eritematoso sistémico. Revista Colombiana de Reumatología, 20, 195-201. https://doi.org/10.1016/s0121-8123(13)70133-6
Condori, P. and Melva, M. (2020) Clinical Epidemiological Profile of Systemic Lupus Erythematosus—Hospital Carlos Monge Medrano de Juliaca 2015-2019. Degree Thesis. Faculty of Health Sciences, Cesar Vallejo University.
Kokuina, E., Osmin, T.B.T., Luis, F.S.J.W., Araceli, C.C., Yeniset, S.B. and Miguel, E.D.T. (2023) Anti-C1q as a Marker of Lupus Nephritis. Revista Cubana de Medicina General Integral, vol. 62.
http://scielo.sld.cu/scielo.phpscript=sci_arttext&
amp;pid=S00347523232023000400031&lng=en
